Abstract
Head and neck squamous cell cancer (HNSCC) is most commonly a tobacco-related disease, affecting nearly 600,000 people worldwide each year. For decades, HNSCC has been treated successfully with multimodality treatments including, surgery, radiation, and chemotherapy, though the 'perfect' treatment paradigm remains elusive. This review will discuss a number of clinical trials, comparing various combinations of chemotherapy and the settings in which they are most successful. Promising research and recent data on the combination of cytotoxic chemotherapy with new biological agents indicate chemotherapy plays a critical role in treatment of HNSCC and will only continue to improve.
Original language | English (US) |
---|---|
Pages (from-to) | 85-95 |
Number of pages | 11 |
Journal | Indian Journal of Surgical Oncology |
Volume | 1 |
Issue number | 2 |
DOIs | |
State | Published - Apr 2010 |
Externally published | Yes |
Keywords
- Head and neck cancer
- cetuximab
- chemoradiation
- chemotherapy
- induction chemotherapy
- targeted therapy
ASJC Scopus subject areas
- Surgery
- Oncology